Linscomb Wealth’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $323K | Buy |
+5,325
| New | +$310K | 0.01% | 281 |
|
|
2025
Q1 | – | Sell |
-3,894
| Closed | -$220K | – | 293 |
|
|
2024
Q4 | $220K | Sell |
3,894
-787
| -17% | -$44K | 0.01% | 282 |
|
|
2024
Q3 | $242K | Sell |
4,681
-306
| -6% | -$14.4K | 0.01% | 271 |
|
|
2024
Q2 | $207K | Sell |
4,987
-642
| -11% | -$28.7K | 0.01% | 282 |
|
|
2024
Q1 | $305K | Sell |
5,629
-422
| -7% | -$21.5K | 0.02% | 240 |
|
|
2023
Q4 | $310K | Sell |
6,051
-1,045
| -15% | -$54.9K | 0.02% | 243 |
|
|
2023
Q3 | $412K | Sell |
7,096
-166
| -2% | -$10.2K | 0.02% | 218 |
|
|
2023
Q2 | $464K | Sell |
7,262
-2,075
| -22% | -$139K | 0.03% | 218 |
|
|
2023
Q1 | $647K | Sell |
9,337
-2,279
| -20% | -$161K | 0.03% | 191 |
|
|
2022
Q4 | $836K | Buy |
11,616
+3,267
| +39% | +$246K | 0.04% | 191 |
|
|
2022
Q3 | $594K | Buy |
8,349
+373
| +5% | +$27.1K | 0.04% | 184 |
|
|
2022
Q2 | $614K | Sell |
7,976
-2,783
| -26% | -$212K | 0.04% | 187 |
|
|
2022
Q1 | $786K | Buy |
10,759
+1,799
| +20% | +$121K | 0.04% | 195 |
|
|
2021
Q4 | $559K | Buy |
8,960
+310
| +4% | +$18.2K | 0.03% | 223 |
|
|
2021
Q3 | $512K | Buy |
8,650
+296
| +4% | +$19.5K | 0.03% | 219 |
|
|
2021
Q2 | $558K | Hold |
8,354
| – | – | 0.03% | 208 |
|
|
2021
Q1 | $527K | Buy |
8,354
+836
| +11% | +$52K | 0.03% | 206 |
|
|
2020
Q4 | $466K | Sell |
7,518
-119
| -2% | -$7.32K | 0.03% | 207 |
|
|
2020
Q3 | $460K | Buy |
7,637
+271
| +4% | +$16.3K | 0.03% | 199 |
|
|
2020
Q2 | $433K | Buy |
7,366
+256
| +4% | +$15.3K | 0.03% | 205 |
|
|
2020
Q1 | $396K | Sell |
7,110
-1,212
| -15% | -$74.1K | 0.04% | 294 |
|
|
2019
Q4 | $534K | Buy |
8,322
+2,862
| +52% | +$164K | 0.03% | 315 |
|
|
2019
Q3 | $277K | Sell |
5,460
-1,043
| -16% | -$49K | 0.02% | 231 |
|
|
2019
Q2 | $295K | Buy |
6,503
+1,794
| +38% | +$83.6K | 0.02% | 224 |
|
|
2019
Q1 | $225K | Sell |
4,709
-160
| -3% | -$7.97K | 0.02% | 244 |
|
|
2018
Q4 | $253K | Sell |
4,869
-901
| -16% | -$48.4K | 0.02% | 223 |
|
|
2018
Q3 | $358K | Buy |
5,770
+918
| +19% | +$54.5K | 0.03% | 214 |
|
|
2018
Q2 | $269K | Buy |
4,852
+96
| +2% | +$5.18K | 0.02% | 234 |
|
|
2018
Q1 | $301K | Hold |
4,756
| – | – | 0.03% | 216 |
|
|
2017
Q4 | $291K | Buy |
4,756
+1,281
| +37% | +$80.1K | 0.02% | 222 |
|
|
2017
Q3 | $221K | Buy |
+3,475
| New | +$203K | 0.02% | 245 |
|
|
2017
Q2 | – | Sell |
-3,733
| Closed | -$203K | – | 251 |
|
|
2017
Q1 | $203K | Buy |
+3,733
| New | +$205K | 0.02% | 237 |
|
|
2016
Q3 | – | Sell |
-3,636
| Closed | -$267K | – | 249 |
|
|
2016
Q2 | $267K | Buy |
+3,636
| New | +$257K | 0.03% | 215 |
|
|
2015
Q2 | – | Sell |
-3,268
| Closed | -$211K | – | 271 |
|
|
2015
Q1 | $211K | Buy |
+3,268
| New | +$205K | 0.02% | 255 |
|
|
2014
Q3 | – | Sell |
-30,945
| Closed | -$1.5M | – | 282 |
|
|
2014
Q2 | $1.5M | Sell |
30,945
-310
| -1% | -$15.3K | 0.16% | 91 |
|
|
2014
Q1 | $1.62M | Buy |
31,255
+3,074
| +11% | +$164K | 0.18% | 81 |
|
|
2013
Q4 | $1.5M | Buy |
28,181
+7,798
| +38% | +$397K | 0.18% | 76 |
|
|
2013
Q3 | $943K | Buy |
20,383
+1,556
| +8% | +$68.3K | 0.12% | 93 |
|
|
2013
Q2 | $841K | Buy |
+18,827
| New | +$817K | 0.12% | 101 |
|
Other funds holding BMY
VCM
VPM
Linscomb Wealth's BMY Position: Q1 2026 in Review
Linscomb Wealth opened a new position in Bristol-Myers Squibb (BMY) in Q1 2026: 5,325 shares worth $323K. The stake represents 0.01% of the portfolio and ranks #281 among its holdings. This is a return to the name: Linscomb Wealth previously reported a position in BMY as recently as Q4 2024.
Linscomb Wealth first reported a position in BMY in Q2 2013 and has held it in 39 quarters since. The position peaked at $1.62M in Q1 2014. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Linscomb Wealth held 5,325 shares of Bristol-Myers Squibb worth $323K as of Q1 2026.
- Bristol-Myers Squibb was a new Linscomb Wealth position in Q1 2026.
- Bristol-Myers Squibb made up 0.01% of Linscomb Wealth's portfolio in Q1 2026, its #281 holding.
- Linscomb Wealth first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 39 quarters since.
- Linscomb Wealth's Bristol-Myers Squibb position peaked at $1.62M in Q1 2014.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Linscomb Wealth's 13F filing for Q1 2026, filed 11 May 2026.